CUSTOMEDIX CORP
10-Q/A, 1995-06-20
DENTAL EQUIPMENT & SUPPLIES
Previous: AMERICAN GENERAL FINANCE CORP, 424B3, 1995-06-20
Next: DEERE JOHN CAPITAL CORP, S-3, 1995-06-20



<PAGE>   1
                                    FORM 10-Q/A

                       SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON D.C. 20549

(MARK ONE)

/X/         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 1995
                                       OR

/ /         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to 
                               -----------------   ------------
Commission file number 1-7081

                             CUSTOMEDIX CORPORATION
              (Exact name of registrants specified in its charter)

         Delaware                                 #22-1844840
(State or other jurisdiction of       (I.R.S. Employer Identification No.)
 incorporation or organization)

         P. O. Box 724, 53 North Plains Industrial Road, Wallingford, CT 06492
                    (Address of principal executive offices)
                                   (Zip Code)

                                  203-284-9079
              (Registrant's telephone number, including area code)
        ----------------------------------------------------------------
   (Former name, former address and former fiscal year, if changed since last
                                    report)

         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.



  Yes  X     No
      ---       ---
         Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the close of the period covered by this report.

         Class                             Outstanding at March 31, 1995 
Common stock $.01 par value                            3,691,064


<PAGE>   2

                               SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

May 10, 1995                                Customedix Corporation
- ------------                                ------------------------
Date                                        Registrant

                                            /s/Gordon S. Cohen 
                                            ------------------------
                                            Gordon S. Cohen
                                            Chairman and Chief Executive Officer

                                            /s/Barry L. Kosowsky              
                                            ------------------------
                                            Barry L. Kosowsky
                                            Principal Financial Officer
                                            Principal Accounting Officer

                                       12


<PAGE>   3
                               INDEX TO EXHIBIT


 EXHIBIT 27.     Financial Data Schedule

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1995
<PERIOD-END>                               MAR-31-1995
<CASH>                                         159,724
<SECURITIES>                                     3,088
<RECEIVABLES>                                7,029,995
<ALLOWANCES>                                   391,000
<INVENTORY>                                  7,882,959
<CURRENT-ASSETS>                            14,845,355
<PP&E>                                       6,835,215
<DEPRECIATION>                               3,631,442
<TOTAL-ASSETS>                              23,462,279
<CURRENT-LIABILITIES>                        4,487,972
<BONDS>                                              0
<COMMON>                                        36,911
                                0
                                          0
<OTHER-SE>                                  10,634,109
<TOTAL-LIABILITY-AND-EQUITY>                23,462,279
<SALES>                                     37,124,566
<TOTAL-REVENUES>                            37,506,613
<CGS>                                       26,977,964
<TOTAL-COSTS>                               35,990,781
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             666,797
<INCOME-PRETAX>                                849,156
<INCOME-TAX>                                   285,000
<INCOME-CONTINUING>                            564,156
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   564,156
<EPS-PRIMARY>                                      .15
<EPS-DILUTED>                                      .15
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission